Compressed SPEEDER Technology for 3D Exams On 1.5T MR, Enabling High-speed MR Imaging Now FDA Approved

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

December 21, 2020

Compressed SPEEDER technology for 3D exams has been FDA-cleared for 3D sequences on Canon Medical Systems USA, Inc.’s Vantage Orian 1.5T MR system, so clinicians can easily expect to scan at least twice as fast, and even faster in many clinical scenarios*.

Compressed SPEEDER 3D** boosts MRI scan times during 3D sequences for exams such as surgical planning and orthopedic applications by reconstructing full resolution images from under-sampled data through iterative reconstruction. The innovative technique overcomes many of the limitations inherent to traditional parallel imaging and allows for greater acceleration. The system can even further accelerate exams with Fast3D, a new technique that can be used in combination with Compressed SPEEDER 3D to help make exams even quicker.

Compressed SPEEDER technology is available as an option in an all-new new version of M-Power software for the Vantage Orian 1.5T, which is also available with Fat Fraction Quantification**, an application integrated directly onto the system’s console to help clinicians image and quantify fatty liver disease. The application acquires six MR echoes at once, allowing for quick diagnoses, detailed severity grading, disease monitoring and treatment response, all in alignment with QIBA standards.

“With 30 percent of the U.S. population suffering from Fatty Liver Disease, the ability to diagnose quickly as well as quantify and monitor the disease has become extremely important to clinicians. Our Fat Fraction Quantification is an ideal solution, and it is on our Vantage Orian 1.5T console so that it can be integrated into existing workflow,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc.

Furuyama concluded, “At Canon Medical, our priority is to support our customers and their patients by providing them with timely advancements that can impact their outcomes and workflow. With the help of Compressed SPEEDER for 3D exams along with Fat Fraction Quantification, healthcare providers can offer a quick and comfortable experience for their patients.”


* Actual acceleration factors vary by case. Maximum acceleration factor is up to 16 times.

** Compressed SPEEDER 3D and Fat Fraction Quantification are both optional. Fat Fraction Quantification is FI-Quant.

Vantage Orian and Made for life are trademarks of Canon Medical Systems.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.